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Coronavirus discontinuous transcription uses a highly conserved sequence (CS) in the joining of leader and
body RNAs. Using a full-length infectious construct of transmissable gastroenteritis virus, the present study
demonstrates that subgenomic transcription is heavily influenced by upstream flanking sequences and supports a
mechanism of transcription attenuation that is regulated in part by a larger domain composed of primarily
upstream flanking sequences which select appropriately positioned CS elements for synthesis of subgenomic RNAs.
Transmissible gastroenteritis virus (TGEV), the causative
agent of acute gastroenteritis in swine, is a member of the
Coronaviridae family, order Nidovirales (29). TGEV possesses
a single-stranded, positive-sense 28.5-kb RNA genome that
expresses eight large open reading frames (ORFs), which are
expressed from full-length or subgenomic-length mRNAs dur-
ing infection (9, 17). TGEV uses a copy choice discontinuous
transcription mechanism for subgenomic mRNA synthesis, re-
sulting in the synthesis of a 3 coterminal nested set of sub-
genomic mRNAs that all contain a 5-proximal leader RNA se-
quence, which is derived from the 5 end of the genome (28).
Although each mRNA is polycistronic, the 5-most ORF is pref-
erentially translated, and with the exception of ORF 3b, a distinct
mRNA species for each ORF is synthesized (20, 27, 28).
Each of the TGEV ORFs is preceded by a transcription
regulatory sequence (TRS) which contains a highly conserved
sequence (CS) of six nucleotides (nt) in length (5-CUAAAC-
3) that functions in the synthesis of each of the subgenomic
mRNAs (1, 5, 31). This same CS sequence is located within the
genomic 5 leader RNA sequence, suggesting that base pairing
between 5 leader RNAs and TRS regions plays an important
role in coronavirus discontinuous transcription (16, 17). With
the equine arterivirus (order Nidovirales) cDNA clone, base
pairing between the leader and body CS regions was required
for efficient subgenomic transcription (33). In addition, the
stability of the leader-body RNA CS interaction was recently
shown to be an important factor in the regulation of sub-
genomic mRNA transcription (23, 24). However, it has be-
come increasingly clear that genomic location and CS flanking
sequences are also important and that the simple insertion of
CS sequences may not be sufficient in initiating subgenomic
transcription (2, 3, 12–14, 18, 19, 22, 32, 34). In addition, a
number of noncanonical transcription start sites have been
noted within the green fluorescent protein (GFP) gene cloned
into the mouse hepatitis virus and TGEV genomes and cannot
be explained by a simple base-pairing model (8, 10). Additionally,
transcription utilizing noncanonical CS sequences has been dem-
onstrated for mouse hepatitis virus, bovine coronavirus and ar-
teriviruses (13, 22, 26). As a result, the exact sequence require-
ments for coronavirus subgenomic transcription remain
unknown, especially in the context of genome-length RNAs.
Until recently, a number of technical barriers have pre-
vented the generation of a coronavirus infectious cDNA clone,
including sequence toxicity and the large genome size (1, 35).
Consequently, the major observations concerning the structure
and function of coronavirus TRS sequences in discontinuous
transcription have been made by using defective interfering
(DI) RNAs that are significantly smaller than wild-type
genomic RNAs and are assembled from different regions of
the viral genome. These RNAs require a helper virus for their
replication and replicate faster than full-length genomic
RNAs. Because DI RNAs are not authentic with respect to an
intact genomic RNA, it is possible that findings using DI RNAs
may differ in the context of the complete genome. In this study,
we sought to identify the TGEV N gene TRS unit sequence
required for driving efficient subgenomic transcription within
the context of a full-length genomic RNA of TGEV.
Construction of recombinant TGEV encoding mutated ORF
3a TRS sequences. We have recently described the construc-
tion of a recombinant TGEV that expresses GFP from the
ORF 3a locus (TGEV-GFP2PflMI) (8, 35). This virus ex-
presses gfp with the ORF 3a CS and 20 nt from the N gene
TRS region (including the CS) upstream of the start codon (3a
CS–N CS- gfp start). However, the more upstream ORF 3a CS
is preferentially used for the synthesis of ORF 3a mRNA from
this virus, indicating that the simple insertion of the 20-bp N
gene TRS sequence was not sufficient for directing efficient
mRNA synthesis from this location. It is possible either that
the inserted 20-nt N gene TRS sequence does not represent a
functional N gene TRS element or that the upstream ORF 3a
TRS suppresses transcription from proximal TRS elements.
Using the TGEV-GFP2PflMI construct as a background, we
used recombinant DNA approaches to assemble recombinant
viruses that contained an active N gene CS for the synthesis of
leader-containing transcripts expressing gfp.
To determine whether the ORF 3a TRS present within
TGEV-GFP2PflMI suppressed subgenomic mRNA transcrip-
tion from the inserted 20- nt N gene TRS sequence, we assem-
bled a construct containing the deletion of the ORF 3a CS and
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89 nt of 5 flanking sequence, TGEVmut1 (Fig. 1A). By 18 h
posttransfection, GFP expression was observed by fluorescence
microscopy in cultures transfected with full-length TGEVmut1
RNA (data not shown). The supernatant was harvested from
the transfected culture, and plaque-purified virus stocks ex-
ceeded 107 PFU/ml by 24 h postinfection. At 12 h postinfec-
tion, total cellular RNA was harvested and used as a template
for reverse transcription-PCR (RT-PCR) to detect leader-con-
taining mRNA expressing gfp. A GFP leader containing an
amplicon of 850 bp was isolated that contained leader-body
junctions derived from the 20-nt N gene TRS element (nine of
nine independent clones sequenced) (Table 1). These data
indicate that the inserted 20-nt N gene TRS is functional in the
absence of the upstream ORF 3a CS plus 89 nt of 5 flanking
sequence and that use of this 20-nt N TRS sequence is likely
suppressed by the presence of a functional ORF 3a TRS in the
TGEV-GFP2PflMI recombinant virus. By Western blot anal-
ysis, GFP expression was clearly impaired in the TGEVmut1-
infected cells compared with the expression in the TGEV-
GFP2PflMI parent (Fig. 2).
To further examine N gene TRS functionality and to deter-
mine whether the ORF 3a TRS was suppressing transcription
from the 20-nt N gene TRS, the ORF 3a CS sequence in the
TGEVmut2 construct was mutated (ACUAAAC3GCUA
CAC), such that only a perfect N gene CS sequence was po-
sitioned upstream of gfp (Fig. 1B). In this construct, only the
ORF 3a CS has been mutated, while the 5 and 3 flanking
sequences were not modified. GFP expression was evident in
TGEVmut2-transfected cultures by fluorescence microscopy at
18 h posttransfection (data not shown), and infectious virus
was recovered that grew in swine testicular (ST) cells to titers
approaching 108 PFU/ml. Total cellular RNA was harvested
14 h postinfection and subjected to RT-PCR for detection of
subgenomic mRNA expressing gfp. Sequence analysis of leader-
containing gfp amplicons revealed that mutation of the ORF 3a
CS activated the downstream N gene TRS element (10 of 10
independent clones) (Table 1). These data demonstrate that the
20-bp N TRS sequence is functional, but only in the absence of
the upstream ORF 3a CS. Consistent with these studies and
FIG. 1. TGEV recombinant viruses expressing GFP. A series of TGEV recombinant viruses was generated using the TGEV-GFP2PflMI
construct as the backbone for further characterization of the 3a and N gene TRS. (A) The TGEV-GFP2PflMI parent construct contains an ORF
3a deletion and insertion of GFP under the control of the 3a TRS and 20 nt of the N gene TRS. The location of the N and/or ORF 3a TRS
sequences upstream of gfp is indicated. Clones were identified by DNA sequencing using an ABI model 377 automated sequencer, and the resulting
constructs were subsequently used in the assembly of recombinant TGEV viral cDNAs. (B) TGEVmut1 was constructed by deleting nt 24709 to
24804 of the TGEV genome from TGEV-GFP2PflMI, corresponding to the ORF 3a CS and 89 nt of its 5 flanking sequence. (C) TGEVmut2
contains the mutation of the upstream ORF 3a CS (ACUAAAC3GCUACAC), such that only the N CS is positioned upstream of gfp. (D)
TGEVmut3 contains the 5 N CS flanking sequence, which has been extended from 8 to 47 nt, (corresponding to nt 26858 to 26904 of the TGEV
genome; GenBank accession no. AJ271965) while leaving the upstream ORF 3a CS completely intact. (E) TGEVmut4 contains the insertion of
a nonspecific 39-nt sequence just 5 of the 20 nt N gene TRS. (F) TGEVmut5 was engineered to contain unique StuI and Esp3I restriction sites
which flank the CS element upstream of the N gene, and unique BstEII and PacI sites were introduced at the 3 end of the N gene. The PacI restric-
tion site was introduced at nucleotide position 28063 of the TGEV genome by mutagenesis of the Hp gene CS (ACTAAAC3ATTAATTAA). The
wild-type Hp CS and gene were then repositioned just downstream of this PacI site, including 10 bp of upstream 5 flanking sequence (nt 28051
to 28060). (G) To generate TGEVmut6, a 500-bp amplicon representing the CS deletion and 5-truncated Hp gene was generated using the PacI
site containing the 5 primer (5-TTA ATT AAA CCG GTT CGT CTT CCT CCA TGC TG-3) and a 3 primer within the cloning vector (Topo
XL TA cloning vector; Invitrogen. Using the unique PacI site, this amplicon was inserted into the TGEVmut5 background to replace the wild-type
Hp gene, resulting in a new recombinant TGEV F fragment containing a deletion of the CUAAAC Hp CS and 7 nt of 3 flanking sequence (nt
28051 to 28074), including the first 4 nt of the Hp ORF. The only two available ATG start codons are out of frame with respect to the Hp ORF
at nt positions 28087 and 28186 and would encode a seven- and nine-amino-acid protein, respectively.
TABLE 1. Origin of leader-containing GFP transcripts
Recombinant
virus
No. of clonesa
TGEV 3a CS TGEV N CS
TGEVmut1 0/9 9/9
TGEVmut2 0/10 10/10
TGEVmut3 1/10 9/10
TGEVmut4 7/7 0/7
a Number of leader-containing GFP cDNA clones that originated from either
the 3a or N CS site/number total.
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following normalization to N protein expression levels (data not
shown), deletion of the ORF 3a CS site and 5 flanking sequence
in the TGEVmut1 virus resulted in about 70 to 80% less GFP
expression than with TGEV-GFP2PflMI. Under conditions of an
intact upstream 3a TRS region but CS knockout, the TGEVmut2
virus expressed about 22% less GFP than TGEV-GFP2-PflMI, as
determined by Western blot analysis (Fig. 2).
In a previous study using TGEV-derived minigenomes, tran-
scription levels from the N gene TRS were significantly en-
hanced by the extension of CS 5 flanking sequence (2). There-
fore, we sought to determine if any suppressing effect from the
ORF 3a TRS might be overcome by increasing the N CS 5
flanking sequence. Consequently, we assembled the recombi-
nant virus TGEVmut3 in which the 5 N CS flanking sequence
has been extended from the 8 nt in TGEV-GFP2-PflMI to 47
nt (26858 to 26904) while leaving the upstream ORF 3a TRS
completely intact (Fig. 1C). To control for the increased spac-
ing between the 3a and N CS sequences, we also constructed a
TGEVmut4 control, which contained the insertion of a non-
specific 39-nt sequence just 5 of the 20-nt N gene TRS ele-
ment (Fig. 1D). By 18 h posttransfection, GFP expression was
observed by fluorescence microscopy in the TGEVmut3-trans-
fected cultures but not in the TGEVmut4-transfected cultures
(data not shown). Supernatants were harvested from both
transfections and passed onto fresh cultures of ST cells, and
infectious virus was isolated. At12 to 18 h postinfection, total
cellular RNA was harvested and used as a template for RT-
PCR to detect leader-containing mRNA expressing gfp. Am-
plicons of 850 bp were isolated from both cultures (data not
shown), cloned, and subsequently sequenced to determine
which TRS was utilized in these two viruses. Subgenomic
mRNA transcription was almost exclusively initiated from the
N gene CS in the TGEVmut3 recombinant virus (9 of 10 inde-
pendent clones), while subgenomic mRNA synthesis was exclu-
sively initiated from the ORF 3a CS of TGEVmut4 (7 of 7
independent clones) (Table 1). In contrast to transcription pro-
files noted in the TGEV-GFP2PflMI virus, upstream flanking
sequences activated the N CS even in the presence of the ORF 3a
CS. This N gene TRS element was comprised of the 5-CUAAA
C-3 consensus sequence, 6 nt of 3 flanking sequence and 47 nt
of 5 flanking sequence. Furthermore, these data show that the
activation of the N CS in TGEVmut3 was not simply a result of
increasing the distance between the two TRS elements. Rather,
these data are consistent with the hypothesis that CS location in
relationship to the flanking sequence context is central to the
regulation of subgenomic RNA transcription.
Studies using DI RNAs engineered to encode two closely
positioned CS sequences have demonstrated that downstream
CS sequences suppress subgenomic mRNA transcription from
upstream CS sequences and that upstream CS sequences have
little or no effect on downstream CS sequences (12, 14, 15, 34).
Additionally, it is apparent that the nature of the flanking
sequences themselves and not any secondary structures may be
the primary determinant of the site for leader fusion (2, 22).
These data are most consistent with transcription attenuation
during negative-strand synthesis, where the TRS acts as an
attenuator, and also explain why the smaller subgenomic
mRNAs are generally produced in larger quantities than the
larger subgenomic mRNAs (4, 25). Data from the present
study are in partial agreement with these previous DI studies in
that they demonstrate the preferential use of a downstream
TRS CS site over a closely positioned upstream CS site
(TGEVmut3 data). However, data from this study also indicate
that these relationships are potentially more complex, as we
have demonstrated that a closely positioned upstream CS can
attenuate transcription from a downstream CS.
We believe that the ORF 3a CS flanking sequences are
optimally positioned to interact with the upstream TRS site. By
position context, the 3a CS site is a preferred site for discon-
tinuous transcription compared with the inserted 20-nt N
TRS, which is only optimally recognized when the normal 3a
CS site is disrupted. Consonant with these findings, positional
effects were overcome by the extension of the N CS 5 flanking
sequence from 8 to 47 nt, which also has been shown to in-
crease N TRS transcription levels in TGEV minigenomes (2).
We believe that this phenomenon was observed because the
addition of N CS upstream flanking sequences in TGEVmut3
reconstituted a functional N TRS site, which preferentially
recognized the position-proximal N CS for discontinuous tran-
scription. If the model is correct, the upstream TRS sequences
likely select the optimal CS sequence that participates in site-
assisted discontinuous subgenomic transcription.
Construction of recombinant TGEV encoding mutated Hp
TRS sequences. Our data, as well as those from previous re-
ports (3, 12, 13, 19, 22, 32, 34), demonstrate the importance of
flanking sequences in CS function in subgenomic mRNA tran-
scription. We and others have hypothesized that the function
of the CS is to serve as an efficient sequence for site-assisted
recombination during discontinuous RNA transcription. If the
TRS regulates transcription attenuation, then disruption of a
normal CS sequence should reveal inefficiently positioned and
utilized CS sites that are in close proximity to the TRS. To test
FIG. 2. GFP expression from TGEV recombinant viruses. ST cells
were infected with wild-type TGEV, TGEVmut2, or TGEVmut3, incu-
bated for 12 h at 37°C, and subsequently lysed. Harvested lysates were
subjected to Western blotting with monoclonal antisera directed against
GFP (Clontech) or the TGEV N protein. Murine antisera against the
TGEV N protein were raised by immunizing mice with Venezuelan
equine encephalitis virus replicon vectors encoding the TGEV N gene.
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this possibility, we altered a second TRS site at another ge-
nome location. We reorganized the N and Hp CS sequences
located at the 3 end of the genome by inserting unique re-
striction sites that flanked the N and Hp TRS elements but did
not disrupt the surrounding ORFs. In the wild-type TGEV
genome, the N gene stop codon and Hp CS overlap at nucle-
otide positions 28063 to 28065. In TGEVmut5, the N CS was
flanked with unique StuI and Esp3I sites, while a unique PacI
site was positioned just downstream of N (Fig. 1E). The N gene
stop codon was positioned within the engineered PacI site
(nucleotide position 28063), and the Hp CS and flanking se-
quences (beginning at position 28051) were reengineered
downstream of this restriction site. The result is the reengi-
neering of the Hp TRS to a more downstream location within
the TGEV genome. Recombinant TGEVmut5 cDNAs were
constructed, and full-length capped, polyadenylated RNAs
were generated in vitro and transfected into BHK cells as
previously described (8, 35). Following electroporation of full-
length transcripts, we rapidly identified recombinant
TGEVmut5 viruses that expressed GFP and replicated to titers
of about 107 by 19 h postinfection (data not shown). These data
demonstrate that the TRS reorganization does not necessarily
interfere with efficient TGEV replication and will allow for the
precise removal of the Hp CS and the mutagenesis of cis-acting
sequences required for TGEV replication. TGEVmut5 should
also provide a means to test sites around the N and Hp genes
as heterologous gene expression sites.
To determine if CS deletion results in the induction of new
leader/body junction sites, the Hp CS sequence and 7 nt of 3
flanking sequence were deleted from TGEVmut5 by primer-
mediated mutagenesis, resulting in the construct TGEVmut6
(Fig. 1F). In addition to deletion of the Hp CS, the first 4 nt of
the Hp gene were removed, including the ATG start codon, in
order to address whether Hp is critical for TGEV replication.
Recombinant TGEVmut6 cDNA was constructed, and full-
length capped, polyadenylated RNAs were generated in vitro
and transfected into BHK cells. Infectious virus was isolated
that grew to titers 2 logs lower than those of either the
parental TGEVmut5 or wild-type TGEV viruses (data not
shown), demonstrating that Hp is not required for TGEV
replication in vitro but that the absence of this 3-terminal
ORF/transcriptional unit is somewhat detrimental to virus rep-
lication. Similar findings have been reported by other labora-
tories (21). GFP expression was observed by fluorescence mi-
croscopy in TGEVmut6-infected ST cell cultures by 18 h
postinfection (data not shown). Importantly, while Hp expres-
sion was apparent by immunofluorescence assay with rabbit
anti-Hp polyclonal antiserum in cultures infected with both
wild-type TGEV and TGEVmut5, expression was not evident
in cultures infected with TGEVmut6 (data not shown).
Intracellular RNA was isolated from infected cultures at
12 h postinfection and analyzed by RT-PCR with a primer
pair located within the leader RNA sequence and at the very 3
end of the TGEV genome. As expected, an amplicon corre-
sponding to leader-containing N gene transcripts was obtained
from wild-type TGEV, TGEV-GFP2PflMI, TGEVmut5, and
TGEVmut6 virus-infected cultures (Fig. 3A). Interestingly, an
amplicon corresponding to leader-containing Hp transcripts
was also obtained from each of these cultures, albeit to a lesser
quantity in the TGEVmut6-infected cultures, despite the de-
letion of the Hp CS from the TGEVmut6 genome. To map the
precise location of the leader-body junctions of the Hp sub-
genomic mRNAs, amplicons were cloned and examined by
sequence analysis. The leader-body junctions of the transcripts
FIG. 3. RT-PCR and sequence analysis of leader-containing tran-
scripts in TGEV-GFP3- and TGEV-GFP4-infected cells. Cultures of
ST cells were infected with TGEV-GFP2, -GFP3, or -GFP4 or wild-
type TGEV derived from the infectious construct (icTGEV 1000) at a
multiplicity of infection of sim for 1 h at room temperature. Intracel-
lular RNA was harvested 12 h postinfection and used as a template
for RT-PCR with the 5 leader-specific primer TGEV-L (5-CACTA
TTAGACTTTTAAAGTAAAGTGAGTGTAGC-3) and a 3 primer
specific to the 3 terminus of the TGEV genome (TGEV 3 end;
5-NNNNNNGCGGCCGCTTTTTTTTTTTTTTTTTTTTTTTTTGG
TGTATCACTATCAAAAGG-3). (A) Agarose gel electrophoresis of
RT-PCR amplicons representing leader-containing subgenomic
mRNA. RT-PCRs were run on 0.8% agarose gels, and amplicons of
1.5 kb and 600 bp were isolated, corresponding to leader-containing
transcripts encoding N and Hp, respectively. A third amplicon of 1.3
kb was isolated that represents leader-containing transcripts driven
from a cryptic start site. (B) Sequence analysis of RT-PCR amplicons
from TGEV-GFP3- and TGEV-GFP4-infected cells. The 600 bp RT-
PCR amplicons from TGEV-GFP3- and GFP4-infected cells shown in
panel A were cloned and sequenced to determine the leader-body junc-
tions. Leader-containing transcripts encoding Hp were exclusively initi-
ated from the CS present just upstream of the Hp ORF in TGEV-GFP3
(six of six independent clones sequenced). Subgenomic mRNA synthesis
was initiated from a variety of locations in TGEV-GFP4, ranging 124 nt
upstream and 42 nt downstream from the original CS location in TGEV-
GFP3 (eight independent clones sequence, each indicated by an arrow).
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obtained from wild-type TGEV- and TGEVmut5-infected cul-
tures were located at the conserved CS sequence,
5-CUAAAC-3 (data not shown). However, the leader-body
junctions of the transcripts obtained from TGEVmut6-infected
cultures varied in their location, ranging from 124 bp upstream
to 42 bp downstream of the original Hp CS position (Fig. 3B).
Although the consensus Hp CS was not present in the
TGEVmut6 genome to allow for complementary base pairing
of the subgenomic RNA with the 5 leader sequence, sequence
analysis revealed regions of sequence homology that may have
allowed for sufficient base pairing, with as little as a 4-nt overlap
(data not shown). These data demonstrate that the conserved CS
sequence, 5-CUAAAC-3, is not required for Hp subgenomic
mRNA synthesis and that Hp CS deletion reveals or activates
poorly utilized noncanonical CS sites at nearby locations. Because
efficient base pairing between body and leader RNAs is important
for efficient production of leader-containing subgenomic mR-
NAs, the new leader-body junction sites contain various amounts
of homology with the leader RNA sequence.
The widely accepted transcription attenuation model hy-
pothesizes that subgenomic RNAs are synthesized during neg-
ative-strand synthesis (25). Subgenomic negative-strand syn-
thesis is regulated by a functional TRS, possibly in conjunction
with bound transcription factors and 3-end proximity (6, 25, 27,
30, 36). Data from this study and others suggest that the TGEV
TRS is a composite of regulatory domains (RD) and a CS site
(Fig. 4) (2, 11, 23). The RD is primarily localized in a 50-nt
domain upstream of the CS site and displays little obvious ho-
mology with 5 leader RNA flanking sequences. While 3 flanking
sequence also contribute (22), our study is not well designed to
measure the contribution of these elements in subgenomic tran-
scription. In this model the CS region serves as a target for
site-assisted recombination during discontinuous transcription.
Given the number of cryptic CS sites identified following deletion
of the HP CS site, transcription attenuation likely generates a
gradient pool of truncated incomplete nascent negative-strand
RNAs that terminate in and around the TRS body CS site. Those
RNAs that most efficiently base pair with the complementary
leader RNA CS sequences are positively selected and function as
templates for primer extension and synthesis of complete nega-
tive-strand templates. Such a mechanism would explain the high
variability in the number of cryptic leader-body CS junctions
noted during coronavirus transcription, the identification of cryp-
tic CS sites following Hp CS inactivation, and the debilitating
effects of CS mutations on discontinuous transcription (7, 8, 26,
37, 38, 39). Importantly, nascent incomplete negative-strand
RNAs might require exonuclease processing for proper align-
ment of complementary CS alignments and discontinuous tran-
scription of the subgenomic negative-strand RNAs, an intriguing
possibility since coronavirus phylogenetic analyses suggest that
ORF 1b encodes homologues of cellular RNA processing en-
zymes (29).
The nature of the upstream TRS regulatory domain is un-
known but may include an undetermined secondary sequence
and structure that includes 3 sequence elements, genome-
wide TRS network signaling, and/or regions that bind specific
viral or cellular proteins. Little conservation is noted upstream
of each body CS site, suggesting that higher-order structures or
undescribed protein binding sites may regulate discontinuous
transcription. This regulatory domain likely signals transcrip-
tion attenuation and positively selects among closely posi-
tioned CS sequences for those sites that function in efficient
site-assisted recombination during the synthesis of complete
subgenomic negative strands. Perhaps it is not surprising that a
variety of different CS sequence motifs have been noted as
sites for subgenomic transcription among the coronaviruses.
Given this model, the actual CS sequence may not be so crit-
ical, with only efficient networking between homologous leader
and body CS sequences needed during discontinuous tran-
scription of subgenomic minus-strand RNAs. Not surprisingly,
efficient coronavirus and arterivirus subgenomic transcription
is maintained when both leader and body CS sites are coordi-
FIG. 4. Model for the TGEV subgenomic TRS. The genomic RNA is the principle template for the synthesis of full-length and subgenomic-
length negative-strand RNAs. Regulation of subgenomic negative-strand synthesis is mediated in part by proximity to the 3 end of the genome
and the presence of a TRS. The TRS is divided into RD and CS, both of which participate in discontinuous transcription. The regulatory domain
of the TRS signals transcription attenuation, and the CS site allows for site-assisted recombination between complementary CS sequences located
in incomplete nascent negative-strand RNAs and in the leader CS sequences encoded at the 5 end of the genome. The nascent negative-strand
RNAs are extended into complete negative strands by acquisition of anti-leader RNA sequences. In the absence of proximal body CS sites, nearby
cryptic sites are inefficiently used in discontinuous transcription of subgenomic negative-strand RNAs.
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nately altered, but not singly (39). Proximity to the TRS reg-
ulatory domain is also critical for subgenomic transcription. In
the case of wild-type virus, the CS site that is proximal to the
upstream RD of the TRS and that is positively selected by base
pairing is used during subgenomic negative-strand synthesis. In
the absence of a specific CS sequence, however, other nearby
sequences are utilized, likely resulting in less-efficient sub-
genomic RNA synthesis. In addition to the present study, this
model is supported by previous studies of bovine coronavirus
and equine arteritis virus TRS elements (22–24). It also seems
likely that regulatory domains in and around the leader RNA
sequence at the 5 end of the genome also contribute to reg-
ulation of discontinuous transcription.
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